Children who were abnormally hypermetropic at the age of6 months were randomly allocated treatment with spectacles or no treatment. The eventual incidence of squint was the same in both groups (approximately 24%). The last known visual acuity of the two groups was not significantly different either. Therefore there is no indication to screen infants with a view to preventing squint/amblyopia by optical correction of hypermetropia. If, however, the children allocated treatment are divided into two subgroups -those who wore glasses consistently and those who probably or certainly did not do so -the incidence of squint was the same, but the last known acuities of those who consistently wore glasses may be better than those who did not do so. This suggests that it may yet prove possible to prevent severe amblyopia.
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A previous paper' described an attempt to prevent squint and/or amblyopia by spectacle correction of abnormal hypermetropia from the age of 1 year. In the event the attempt proved unsuccessful. A possible explanation for this lack ofsuccess could be that treatment was started too late. This is a report of a similar randomised trial of treatment started at the age of 6 months. An assessment of whether glasses were being worn was attempted and recorded each time a child attended. Some children obviously wore the glasses consistently, but it was apparent that some wore them irregularly and others not at all. The 'treated' children were therefore divided into two groups: T+ where compliance was judged (by inspection of the records) to be satisfactory and T± where it was judged to be unsatisfactory. This allocation was made before the analysis of the visual results.
Patients and methods
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Results
Information about the presence of squint
Results ofa randomised trial oftreating abnormal hypermetropiafrom the age of6 months detected by the cover test, corrected visual acuity of the 'worse' eye after all additional treatment including occlusion, compliance with the initial treatment, and the cycloplegic refraction at age 31/2 is available for 285 of the 372 children who originally entered the trial. This forms the basis ofthe results shown above. Three of the children recorded as having squint had divergent squint and the remaining 68 had convergent squint. Even if the children drawn for treatment are split into two subgroups according to their compliance with treatment (T+ and T±), it is clear that treatment from the age of 6 months has not altered the incidence of squint at all (Table I) .
The last known acuities of the 'worse' eye of the children divided into two groups -that is, those drawn for treatment and those drawn for no treatment -are shown in Table II . A statistically significant difference cannot be identified.
Ifthe children drawn for treatment are divided into two subgroups according to their compliance with treatment (T+ and T±), the figures in Table II become those shown in Table III. A statistically significant difference can now be identified if the T+ group are compared with those drawn for no treatment (Table IV) .
Discussion
Abnormal hypermetropia is clearly associated with squint and amblyopia which does not respond to current methods oftreatment.2 In this study the prescription of spectacles from the age of 6 months did not reduce the incidence of squint (Table I) , nor did it lead to a significantly improved final visual acuity after all additional treatment had been given (Table II) . At present, therefore, there is no indication to screen children at the age of 6 months with a view to prescribing spectacles for those who are abnormally hypermetropic in the hope that this will reduce the incidence of squint or reduce the severity of amblyopia.
However, those children who wore their glasses consistently may have achieved a better final visual acuity than those who did not wear glasses (Table III) . The evidence for this is not impressive: a significant difference depends on how the figures are arranged for statistical analysis (see Table IV ). These results do no more than suggest that further research into the prevention of amblyopia, as distinct from squint, may yet prove worthwhile.
An incidental observation on this sample of children was that those whose initial hypermetropia became less by the age of 3½12 had a significantly lower incidence of squint and a better last known visual acuity than those whose hypermetropia did not become reduced. This association between emmetropisation34 and the visual outcome is to be explored in more detail in another paper.
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